The FDA has refused to initiate the approval process for Moderna's mRNA-1010 flu vaccine. A US government spokesperson alleged that Moderna's clinical trial exposed participants to an increased risk of severe illness, leading the FDA to decline considering the vaccine for approval. The reasons for the FDA's decision and the details of the alleged safety concerns are unclear from the provided information.
FDA Initially Refuses to File Moderna's mRNA-1010 Flu Vaccine Application Over Trial Design Concerns
Informational, non-clinical synthesis informed by published research. Not a clinical guideline or medical advice. May contain errors or editorial interpretation. Consult the original source and your physician.
